About US
Contact us
>>Back
SFDA issues notice on effective utilization of ADR monitoring data
- Publisher：
- Publication：2012/5/2
The State Food and Drug Administration (SFDA) recently issued a notice on effective utilization of adverse drug reaction (ADR) monitoring data. The notice requires to make effective analysis, evaluation and utilization of ADR monitoring data, enhance the responsibility awareness and risk awareness of manufacturing enterprises and further strengthen daily management of ADR monitoring.